for the PFDN Purpose: To establish validity for the Pelvic Floor Disorders Network (PFDN) self-administered Adaptive Behavior Index (ABI) and to assess whether ABI assesses known discordance between severity of pelvic floor symptoms and self-reported bother.
Women with pelvic floor disorders report adopting a range of behaviors to avoid embarrassment or mitigate their symptoms. In fact, those with UI or FI may be able to engage in their usual activities by resorting to behaviors with varying levels of complexity that may include wearing pads to absorb leakage, shopping only in stores with public restrooms, avoiding foods and beverages before going out, wearing only dark clothing, or carrying changes of clothes. 6 Some may avoid social or physical activities to limit their discomfort from a vaginal bulge or leakage of urine and/or stool.
Conceptually, these behaviors are the social manifestations of the human ability to adapt to various environmental and life challenges. Among these challenges are the often-embarrassing symptoms that arise from pelvic floor disorders in women and their negative impact on quality of life. Whereas medical management options are available, they are not uniformly used, leaving many to adapt to the effects of UI and FI as well as the disfigurement of POP. Moreover, these seemingly well-intentioned adaptive behaviors may have collateral consequences, such as social isolation, anxiety, or the financial costs associated with absorbent products. To date, there have been no measures to quantify these adaptive behaviors among women with pelvic floor disorders.
Despite the prevalence of pelvic floor disorders, little is known about the extent or impact of adaptive behaviors used by women with UI, FI, and/or POP. Some clinicians and researchers believe that adaptive behaviors may modulate a symptom's impact. If so, one would expect that greater symptom severity, as a measure of the weight of environmental challenge, should be associated with greater use of adaptive behaviors. Similarly, if a medical intervention successfully resolves the pelvic floor disorder, then one might observe a reduced reliance on adaptive behaviors.
To enable investigation of the use and effects of adaptive behaviors, a 7-site clinical trials network, the Pelvic Floor Disorders Network (PFDN), developed a 24-item draft adaptive behavior measure, initially titled "Measure of Adaptations for Pelvic Symptoms" (MAPS). Development of this preliminary instrument included extensive literature review, input from clinical experts, telephone-administered pilot study of 42 women, and 6 focus groups composed of women with UI, FI, and/or POP. 7 Analysis of the focus group data yielded 8 adaptation themes (disclosure, seclusion, being prepared, planning, clothing considerations, sexuality, order and intensity, and outlook) that were used to further refine the preliminary adaptation measure.
The overarching goal of this body of work is to identify important concepts that contribute to quality of life not captured by measuring symptom severity or other condition-specific patientreported measures. 7 The objective of the present study was to finalize and validate the resulting measure, now named the Adaptive Behavior Index or ABI. The ABI measures adaptive behaviors among women with pelvic floor disorders and may be useful in quantifying variations in symptom severity when compared with symptom bother, impact, and overall quality of life.
METHODS

Study Sample
Six distinct study datasets were used to evaluate this instrument. The datasets were created from NIH-funded PFDN observational and interventional trials conducted between 2005 and 2013 (Appendix Table 1 , http://links.lww.com/FPMRS/A29). These studies enrolled women with a variety of pelvic floor disorders including UI, FI, and/or POP. Details of each study have been published. [8] [9] [10] [11] [12] Depending on the period of enrollment, a convenience subset of women from these trials was also enrolled in this study, resulting in a total study population of 873 women. All participating clinical sites obtained institutional review board approval, and each participant provided informed research consent for this project.
Instrument Design
We developed a multiscale, quantitative instrument that captured the major themes generated in our prior assessment of adaptive behaviors. Initially, we began with the list of 24 items in the MAPS, developed by Wren et al. 7 All participants completed the MAPS. For the subset of PFDN studies that involved an intervention, women completed the MAPS before and after the intervention. Only baseline responses were used for the purpose of instrument development. Postintervention responses were used to examine the ABI's responsiveness.
To refine the domains for ABI, we divided the study population into an item selection/domain development subset and a validation/confirmatory factor analysis subset. At the time of the instrument development, the population from each of the 6 studies comprised 605 eligible cases. These were randomly selected for measure development (n = 304) and measure validation (n = 301). Subsequently, additional cases were accrued as the PFDN trials continued enrollment (n = 268) and were added to the validation subset, resulting in the final validation cohort of 569 subjects. A subgroup of 111 women that included those with primary problems of UI, FI, and/or POP was assessed for 2-week testretest reliability before any interventions (Appendix Table 1 ).
At the onset, our task was to select from the original 24 MAPS items those that contributed to 1 or more key concepts (ie, potential domains) related to adaptation while eliminating those that were poorly correlated to each other and their scale. From the development subset, we examined missing item responses and looked for ceiling and floor effects. Items with significant missing responses (greater than 20%) and those that were highly skewed (greater than 90% responding in 1 direction) were eliminated. We then performed exploratory factor analyses to discover underlying domains, keeping factors with an eigenvalue greater than 1.0. We then examined the factor loading to identify items that loaded poorly or loaded on multiple domains. Item-scale correlations, with item deletion, were used to check for internal consistency during development, and any items were eliminated if the Pearson r was less than 0.20. Confirmatory factor analyses with varimax rotation, correlations as measures of construct validity and responsiveness, and measures of reliability (both internal consistency and test-retest) were then carried out in the validation subset. The final instrument and scoring instructions are included as Appendix Tables 2, http://links.lww.com/ FPMRS/A30 and 3, http://links.lww.com/FPMRS/A31.
Domain Scoring
Five response options (never, rarely, sometimes, often, always) were used for each item in the ABI questionnaire. Each item was weighted equally. We linearly transformed these frequency responses into a 0 to 100 scale, then averaged to comprise the composite score for each domain. Thus, a higher domain score represented greater use of adaptive behaviors. 
Construct Validation Studies
Because there are no preexisting measures of adaptive behaviors for pelvic floor disorders, it was not possible to establish criterion validity. We did assess construct validity by coadministration of condition-specific measures with the ABI. Based on our concept of adaptive behaviors, we hypothesized that women with the greatest degree of symptom severity and health related quality of life (HRQOL) impact would report the highest use of adaptive behaviors. We measured the severity of symptoms due to pelvic floor disorders using the validated PFDI (range, 0-300 for UI and POP subscales and 0-400 for colorectal anal subscale, with higher scores indicating more symptoms) 13 and condition-specific HRQOL using the PFIQ (range 0-400, with higher scores indicating greater impact). 13 Face and content validity of these items have been established previously for MAPS and were not repeated in the current study. 7 
Responsiveness
Given that a subset of our validation cohort underwent discrete interventions to treat UI, FI, and/or POP and our concept that adaptive behaviors should lessen with adequate treatment of the underlying pelvic floor disorder, we hypothesized that the ABI would be responsive to symptom changes after intervention. We chose this approach because it is well accepted that not all women will respond equally to such interventions, even those that are surgical in nature. Thus, rather than assuming that a nonzero change would be significant, we evaluated the responsiveness of each domain by measuring the relationship between changes in the individual domain scores for the ABI and changes in symptom severity at 3 months and 12 months after treatment using Pearson correlation. Severity of UI was measured using the Incontinence Severity Index (range, 1-12 with higher score indicating more incontinence).
14 Fecal incontinence was measured with the FI Severity Index. 15 The POP was characterized using the validated POP Quantification system, in which ordinal categories describe the extent of vaginal prolapse, ranging from stage 0 (perfect uterovaginal support) to stage 4 (complete vaginal eversion). 16 We further hypothesized that adaptive behavior could ac count for some degree of variance explained by symptoms as measured by the PFDI on condition-specific HRQOL as measured by the PFIQ. To assess this, we constructed 2 regression models based on the validation sample. In model set I, single domains of the PFDI were correlated to the corresponding disease domains of the PFIQ. In model set II, both individual PFDI domains and the ABI domains were regressed on PFIQ domains (in other words, the 2 ABI domains were added to each model from model set I).
Symptoms, HRQOL, and ABI data were collected via telephone interviews conducted from a centralized location with trained staff that specialized in HRQOL telephone interviewing methodology.
All analyses were performed using SAS version 9.12 (SAS Institute, Cary, NC). Statistical testing was 2-sided and a P value of less than 0.05 was considered statistically significant.
RESULTS
Participant Characteristics
Participant characteristics and a brief description of each trial are summarized in Table 1 . Whereas each clinical trial focused on a particular pelvic floor disorder, women often had a combination of these disorders, and treatments varied widely been studies. For the purpose of description, participants are enumerated according to the trial in which they participated. No woman participated in more than 1 trial.
Item Endorsement and Development of Discrete Domains
The items from MAPS were examined for missing responses and distribution using the current study population. There were minimal missing responses (<2%) except for a single item that, by design, was meant to be endorsed only by sexually active women. Several items were skewed toward "never", such that 72% to 79% of women responded never to wearing protective undergarments, using products to control odor, avoiding eating, limiting travel, holding in prolapse, avoiding sitting for long periods, and planning/scheduling around problems. Because these floor effects were not extreme, all items were included in the exploratory factor analysis. Exploratory factor analysis using the development sample of 304 women revealed 3 factors explaining more than 50% of the variance. Three of the 24 items failed to load on any of the 3 domains (items 10 "limiting foods that irritate," 18 "holding in prolapse," 24 "limiting sexual activity), whereas 3 loaded on more than 1 domain (items 5 "wearing dark/long clothing," 6 "urinating whenever possible," 8 "limiting fluid intake"). These 6 items were then excluded and a second exploratory factor analysis performed with the remaining 18 items. This analysis demonstrated a 3-factor solution. However, item 12 "bathe/shower more than once a day" loaded on 2 factors. Subsequently, this item was also excluded, leaving the preliminary index with 17 items and 3 domains: avoidance, hygiene, and disclosure.
Using the development sample, the initial assessment of internal consistency revealed that factor 3, the disclosure domain (items 22 and 23 "dealing with problems with/without telling people"), had an unacceptably low reliability with a coefficient of 0.59. Based on the lack of sufficient homogeneity, the disclosure domain was eliminated, resulting in the final ABI measure (Appendix Table 2 ), which consists of 17 items within 2 domains-avoidance (11 items) and hygiene (6 items). Using the validation subset, confirmatory factor analysis revealed 2 domains with items separated as expected into either the avoidance or hygiene domains.
Reliability
Internal Consistency
Internal consistency was assessed in the validation subset. The Cronbach alpha coefficients for the avoidance and hygiene domains were 0.88 and 0.68, respectively.
Test-Retest Reliability
Analysis of test-retest reliability in the validation subset of 111 women revealed an intraclass correlation coefficient of 0.84 for both the avoidance and hygiene domains.
Validation Studies
Construct Validity
Correlation coefficients for relationships between ABI domains and baseline symptom severity for UI, FI, and/or POP stage ranged from 0.43 to 0.79 (Table 2) . Over time, PFDN trials used different questionnaires based on their individual study objectives. Consequently, actual numbers reported in these analyses are less than the overall study sample. All correlations were statistically significant (P < 0.0001).
Responsiveness to Change
Findings illustrated in Figure 1 show a reduction in mean ABI scores for both the avoidance and hygiene domains evident by 3 months post-treatment and maintained at 12 months. At 12 months, we observed significant correlations between changes in ABI domain scores and changes in UI and FI severity, but no such significant correlation between the ABI and changes in POP stage (Table 3) .
Variance Between Symptoms and Impact
The 2 regression models revealed that the ABI domains explained additional variances of 26%, 8%, and 10% for UI, FI, and/or POP, respectively (Table 4) .
DISCUSSION
According to Wilson and Cleary, 17 biologic disturbances result in symptoms that lead to organic dysfunction that, in turn, impacts health-related quality of life. Conceptually, their model allows nonbiological individual factors such as symptom amplification, personality motivation, and values to impact quality of life. Environmental and personal factors may modify the effect of symptoms on HRQOL through either a direct or indirect impact on perception of dysfunction. For example, depression and anxiety have been associated with UI. 18, 19 As symptoms of UI, FI, and POP become more severe, quality of life decreases. [20] [21] [22] In addition, adaptive behaviors as an individual characteristic can also alter the continuum between biology and HRQOL.
This study extends our prior work by refining the original measure of adaptive behaviors (MAPS) 7 into the current ABI, which incorporates quantitative scoring and explicit domains evaluating avoidance and hygiene behaviors. Our analyses provide empiric evidence that women reporting greater pelvic floor symptom severity are more likely to use adaptive behaviors. However, although the ABI was moderately responsive to changes in UI and FI, it did not seem responsive to changes in the POP Q score. This may reflect the limited power of using a categorical measure where changes in POP Q were fairly consistent. What is yet undetermined is how much change in the ABI domains constitutes a minimally important clinical difference. Nevertheless, the finding that women seem to reduce their use of adaptive behaviors with FIGURE 1. Among the subset of participants who underwent an intervention for pelvic floor disorders, a decrease in use of both hygiene and avoidance behaviors is noted when compared with baseline. This effect is noted at 3 months and sustained at 1 year. changes in their symptoms and condition-specific impact is novel and consistent with our concept of adaptive behaviors.
The ABI quantifies adaptive self-management behaviors and provides a measure to better understand how self-management can affect health-related quality of life. Specifically, we can apply the ABI to statistically examine the effect adaptive behaviors have on the continuum between symptom severity and quality of life. This not only helps to explore how women self-manage these conditions, but also enables researchers to examine the gap between symptom severity, symptom bother, and quality of life. For example, the significant quality of life impact reported by a woman who leaks drops of urine once per week may be explained by the many life-altering restrictions she has placed on herself to avoid urine leakage.
In earlier focus groups, we elicited a number of themes describing a host of adaptations and coping strategies used by women with pelvic floor disorders. Among these, seclusion, being prepared, planning, and clothing considerations were incorporated into the ABI. Other themes, including 2 items related to disclosure, failed to yield sufficient reliability to stand as an independent domain. Similarly, adaptive behaviors related to sexuality, although very important, could not be advanced in our quantitative measure because of the fact that approximately 50% of women were not currently sexually active. Although we have focused on the most highly endorsed adaptive behaviors reported in our prior work, we understand that other adaptive behaviors not included in the ABI are likely used by certain women. Nonetheless, this refined version of the instrument allows us to better understand the magnitude of impact that self-management can have on quality of life.
Many women do not seek medical care for their pelvic floor symptoms. [23] [24] [25] This has been attributed to access issues or lack of appreciation for treatment options. Clinicians are aware that fear, impact on relationships, and cost also play a role. Using the ABI, researchers can now also examine the degree to which adaptive behaviors impact a woman's decision to defer medical attention or recommended treatment. Moreover, tradeoffs in the form of cost and convenience to an individual woman, relative to adaptive behaviors, have yet to be examined. If the findings from our analyses are typical, there is a substantial societal benefit from adaptive behaviors that, heretofore, has gone unmeasured. Whether this self-management is helpful and translates into individual benefit to the woman will require further exploration.
Several limitations of this work should be considered. Our study included only women, limiting the validity of the ABI for men, although they also report UI and FI, albeit at much lower rates. The study population, drawn from participants in clinical studies, was fairly homogeneous. Although the ABI's 2 domains (avoidance and hygiene) incorporate the majority of behaviors endorsed by women with pelvic floor disorders, they are not inclusive. Lastly, we failed to meaningfully advance our understanding of the role of adaptive behaviors relating to sexuality and coping. Although, clearly, these are important areas that emerged in focus group sessions, the lack of uniform endorsement limited our ability to move these themes into the quantitative realm. Further research would be necessary to verify our findings in other populations.
CONCLUSIONS
The ABI is a valid and reliable 2-domain, self-administered measure with established reliability and validity that captures commonly endorsed adaptations by women affected with pelvic floor disorders including UI, FI, and/or POP. The use of adaptive behaviors accounted for a significant proportion of the previously unexplained variance between symptom severity and impact on daily activities. 
